DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/ddpcn7/ovarian_cancer)
has announced the addition of the “Ovarian
Cancer – Pipeline Review, H2 2015” report to their offering.
This report provides comprehensive information on the therapeutic
development for Ovarian Cancer, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Ovarian
Cancer and special features on late-stage and discontinued projects.
The report enhances decision-making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MoAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
- Ovarian Cancer Overview
- Therapeutics Development
- Pipeline Products for Ovarian Cancer – Overview
- Pipeline Products for Ovarian Cancer – Comparative Analysis
- Ovarian Cancer – Therapeutics under Development by Companies
Ovarian Cancer – Therapeutics under Investigation by
- Ovarian Cancer – Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Ovarian Cancer – Products under Development by Companies
Ovarian Cancer – Products under Investigation by
- Ovarian Cancer – Companies Involved in Therapeutics Development
- 3-V Biosciences, Inc.
- 4SC AG
- A. Menarini Industrie Farmaceutiche Riunite Srl
- AB Science SA
- AbbVie Inc.
- Abeona Therapeutics, Inc.
- AbGenomics International, Inc.
- Acetylon Pharmaceuticals, Inc.
- Adaptimmune Limited
- Aduro BioTech, Inc.
- Advanced Accelerator Applications SA
- Advantagene, Inc.
- Advaxis, Inc.
- Advenchen Laboratories, LLC
- Aeterna Zentaris Inc.
- Agilvax, Inc.
- Alchemia Limited
- Alethia Biotherapeutics Inc.
- Almac Discovery Limited
- Ambrx, Inc.
- Amgen Inc.
- Anavex Life Sciences Corp.
- ANP Technologies, Inc.
- Antoxis Limited
- Aphios Corporation
- Aposense Ltd.
- Aprea AB
- arGEN-X BV
- Armour Therapeutics Inc.
- (200+ Others)
For more information visit http://www.researchandmarkets.com/research/ddpcn7/ovarian_cancer
Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716